Artelo Biosciences

ARTL51

Penny Stock

$1.20arrow_drop_down1.31%-$0.01

Penny Stock

ARTL51

$1.20

arrow_drop_down1.31%-$0.01

Penny Stock

Performance History

Key Stats
Open	$1.04
Prev. Close	$1.04
EPS	-3.35
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.93M
PE Ratio	-

	LOW	HIGH
Day Range	1.02	1.29
52 Week Range	1.00	1.78

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-3.35

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Artelo Biosciences (ARTL)

Artelo Biosciences Inc (ARTL) is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of cancer and other diseases. The company is dedicated to leveraging its expertise in cannabinoid-based medicines to address unmet medical needs and improve patient outcomes. With a strong commitment to scientific research and development, Artelo Biosciences is at the forefront of the emerging field of cannabinoid therapeutics.

One of the key metrics used to evaluate the performance of a stock is its price history. Looking at the historical stock price of Artelo Biosciences Inc (ARTL), we can see that it has experienced both ups and downs. Over the past year, the stock price has ranged from a low of $0.50 per share to a high of $2.80 per share. This volatility in the stock price can be attributed to various factors, including market conditions, investor sentiment, and company-specific news.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Gregory D. Gorgas M.B.A.
Headquarters: Solana Beach
Employees: 5
Exchange: NASDAQ

Keep an eye on Artelo Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Artelo Biosciences 's (ARTL) price per share?

The current price per share for Artelo Biosciences (ARTL) is $1.2. The stock has seen a price change of -$0.02 recently, indicating a -1.31% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Artelo Biosciences (ARTL)?

For Artelo Biosciences (ARTL), the 52-week high is $1.78, which is 47.84% from the current price. The 52-week low is $1, the current price is 20.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Artelo Biosciences (ARTL) a growth stock?

Artelo Biosciences (ARTL) has shown an average price growth of -6.8% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Artelo Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Artelo Biosciences (ARTL) stock price performance year to date (YTD)?

As of the latest data, Artelo Biosciences (ARTL) has a year-to-date price change of -12.75%. Over the past month, the stock has experienced a price change of 4.7%. Over the last three months, the change has been -7.38%. Over the past six months, the figure is -21.82%. Looking at a longer horizon, the five-year price change stands at -96.16%.

help

Is Artelo Biosciences (ARTL) a profitable company?

Artelo Biosciences (ARTL) has a net income of -$9.29M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$9.93M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Artelo Biosciences (ARTL)?

Artelo Biosciences (ARTL) has a market capitalization of $3.94M. The average daily trading volume is 1.19, indicating the stock's liquidity and investor engagement.